U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H10N4O4
Molecular Weight 250.2108
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2′,3′-Anhydroinosine

SMILES

[H][C@]12O[C@@]1([H])[C@@H](O[C@@H]2CO)N3C=NC4=C3N=CNC4=O

InChI

InChIKey=WDIGUIIOGAEQHN-KQYNXXCUSA-N
InChI=1S/C10H10N4O4/c15-1-4-6-7(18-6)10(17-4)14-3-13-5-8(14)11-2-12-9(5)16/h2-4,6-7,10,15H,1H2,(H,11,12,16)/t4-,6-,7-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H10N4O4
Molecular Weight 250.2108
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 03:27:51 GMT 2023
Edited
by admin
on Sat Dec 16 03:27:51 GMT 2023
Record UNII
8484S7DCT5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2′,3′-Anhydroinosine
WHO-IP  
Systematic Name English
DIDANOSINE IMPURITY, 2',3'-ANHYDROINOSINE- [USP IMPURITY]
Common Name English
DIDANOSINE IMPURITY E
EP  
Common Name English
Inosine, 2′,3′-anhydro-
Systematic Name English
DIDANOSINE IMPURITY E [EP IMPURITY]
Common Name English
9-(2,3-ANHYDRO-.BETA.-D-RIBOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]
Common Name English
2',3'-ANHYDROINOSINE [WHO-IP]
Common Name English
9-(2,3-anhydro-β-d-ribofuranosyl)-1,9-dihydro-6H-purin-6-one
Systematic Name English
Code System Code Type Description
PUBCHEM
135569030
Created by admin on Sat Dec 16 03:27:51 GMT 2023 , Edited by admin on Sat Dec 16 03:27:51 GMT 2023
PRIMARY
CAS
31766-13-9
Created by admin on Sat Dec 16 03:27:51 GMT 2023 , Edited by admin on Sat Dec 16 03:27:51 GMT 2023
PRIMARY
EPA CompTox
DTXSID20747041
Created by admin on Sat Dec 16 03:27:51 GMT 2023 , Edited by admin on Sat Dec 16 03:27:51 GMT 2023
PRIMARY
FDA UNII
8484S7DCT5
Created by admin on Sat Dec 16 03:27:51 GMT 2023 , Edited by admin on Sat Dec 16 03:27:51 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
In the chromatogram obtained with solution (2), the following peaks are eluted at the following relative retention with reference to didanosine (retention time about 13-15 min): impurity E about 0.5. In the chromatogram obtained with solution (3) the area of any peak corresponding to impurity A (hypoxanthine) is not greater than the area of the principal peak obtained with solution (1) (0.5%). The area of any individual peak corresponding to impurities E not greater than 0.2 times the area of the principal peak obtained with solution (4) (0.2%).
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP